SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABT - Abbott Labs
ABT 125.07+0.4%11:09 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Skywatcher who wrote (308)8/15/2000 11:41:20 AM
From: Skywatcher  Read Replies (1) of 328
 
Abbott seeks dismissal of claim in cancer suit
ABBOTT PARK, Ill., Aug 14 (Reuters) - Abbott Laboratories Inc. (NYSE:ABT - news) on Monday said it filed a motion to dismiss a counterclaim filed by Children's Medical Centre Corp. of Boston in which the hospital accused Abbott of stealing a formula for a promising cancer medicine.
Abbott in May sued Boston's Children's Hospital, claiming the hospital and one of its top cancer researchers, Dr. Judah Folkman, falsely took credit for a medical development in treating malignant tumours.
The hospital, in its July countersuit, accused Abbott of falsifying and manipulating evidence and committing fraud on the court.
Abbott also said Monday it filed a separate motion in Boston's U.S. District Court to dismiss a counterclaim by
biopharmaceutical company EntreMed Inc. (NasdaqNM:ENMD - news) of Rockville, Md. EntreMed is seeking to protect its rights to research at the Boston hospital.
chris
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext